Actively involved with the National Lung Cancer Partnership and American Society of Clinical Oncologists, the Black Lab was established in 2004 at the College of Pharmacy at UK. The group designs wet-lab experiments to determine how control of gene expressions impacts cancer therapy response in patients. Studies consist of patient tumor samples and high- and medium-throughput gene expression analysis of cancer cell lines.
Current Black Lab researchers include doctoral, PharmD, graduate, and undergraduate students. Past lab members have achieved admission into a fellowship program at the American Association of Pharmaceutical Scientists and published a paper in Cancer Biology and Therapy related to inhibition of class IA PI3K enzymes in non-small cell lung cancer cells. More recently, a Black Lab member joined Experimental Biology 2015 to present multiple posters on cancer research.